PPCE Selects eClinicalOS(TM) for Rheumatoid Arthritis Trial

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
PPCE Selects eClinicalOS(TM) for Rheumatoid Arthritis Trial

MORRISVILLE, N.C., Nov. 19, 2014 (GLOBE NEWSWIRE) -- PPCE selected the eClinicalOS data management platform from Merge eClinical for a rheumatoid arthritis study for a Singapore-based pharmaceuticals company. While the number of eClinicalOS-based trials outside the U.S. has grown steadily since its launch in 2012, this study represents the first time the platform has been used to administer a trial in India.

"eClinicalOS is an excellent tool with a range of optional modules such as Translation, e-PRO, Randomization, DICOM Imaging, Endpoint Adjudication and customizable CTMS integrated into a comprehensive, user-friendly platform," said Amit Kumar Yadav, business development manager at PPCE. "The ability to combine the power of an end-to-end study management platform with the scalability offered through the pay-as-you-go option made our decision to go with eClinicalOS an easy one."

Mr. Yadav also noted the eClinicalOS platform's design allowed the PPCE team to build and launch the study in only seven weeks. "Quite frankly, we were surprised at how quickly we could design the study and have it ready to go live, considering that this was the first time we were using the platform."

"Our goal is for eClinicalOS to be the standard data management platform no matter a study's size, complexity or location. We are tremendously excited to expand our global footprint of more than 80 countries to include a critical market such as India," said Merge eClinical President Zaher El-Assi.

Mr. El-Assi also noted that PPCE and its client were specific in the functions and features needed from a data management system. "They wanted a fully integrated software platform that was intuitive, didn't require steep upfront costs and could provide real-time access to clinical data for quick decision-making. That right there is a perfect description of eClinicalOS," he said.

According to Khushnoor Dastoor, executive director and head of quality assurance at PPCE, more stringent regulations coupled with increased cost pressure are pushing the clinical research market to adopt technology to an even greater extent than in recent years. "Clinical research professionals place great faith in systems that are strong on 'fool proofing.' To this end, we want platforms that reduce the need for manual entry and disallow illogical data from being entered, thereby reducing errors through automation. eClinicalOS is an excellent example of that technology," she said.

About Merge eClinical

Merge eClinical is a division of Merge Healthcare, Inc. (Nasdaq: MRGE ), a leading provider of clinical systems and innovations that seek to transform healthcare. eClinicalOS, the company's flagship product, is a single, scalable cloud-based platform researchers can configure to suit a study's precise needs. From monitoring inventory and managing randomization to endpoint adjudication and archiving results, users pay only for the options they use. Studies built within eClinicalOS can launch in as few as 10 days, and the average deployment time from project initiation is 40 days. More information is available at www.eclinicalos.com .

About Merge

Merge is a leading provider of innovative enterprise imaging, interoperability and clinical systems that seek to advance healthcare. Merge's enterprise and cloud-based technologies for image intensive specialties provide access to any image, anywhere, any time. Merge also provides clinical trials software with end-to-end study support in a single platform and other intelligent health data and analytics solutions. With solutions that have been used by providers for more than 25 years, Merge is helping to reduce costs, improve efficiencies and enhance the quality of healthcare worldwide. For more information, visit merge.com and follow us at @MergeHealthcare .

About PPCE

PPCE was founded in 1997 with a vision to add value to industry by encouraging "zero-defect" and the prevention of problems arising out of poor quality.

PPCE offers cost effective clinical data management , bio-statistics and medical writing services for paper based, electronic and hybrid studies. Solutions used are validated, world renowned and regulatory compliant across the globe. Fully validated, 21 CFR Part 11 compliant platforms enable PPCE to offer its clients world-class tools for high-quality data.

We are a company focused on quality and on-time delivery for our clients. PPCE's 16 years of experience certifying companies for quality management means that critical aspects of quality, such as integrity of data, confidentiality and customer orientation, form part of the organizational culture. As a result of this culture, we enjoy a high level of customer satisfaction and long-term relationships with our clients. For more information, visit www.ppceworld.com .

Cautionary Notice Regarding Forward-Looking Statements

The matters discussed in this news release may include forward-looking statements, which could involve a number of risks and uncertainties. When used in this press release, the words "will," "believes," "intends," "anticipates," "expects" and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, such forward-looking statements. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements.

Amit Kumar Yadav PPCE +91 20 26745002 Aaron Mazze Merge eClinical 919.653.3467

Scroll down for more posts ▼

Top 10 Most Recent News Articles

FAMID's Six-Month IVDR Win Opens Europe's Market Door

Updated Category News Views 25

A six-month regulatory sprint is the sort of result that makes a crowded diagnostics field pause and squint. DNV has issued an IVDR certificate to FAMID Biomedical Technology for its E7 Oncoprotein Rapid Test Kit, a Class C in vitro diagnostic intended to aid diagnosis of cervical epithelial cell lesions through detection of HPV E7 oncoprotein in cervical cell samples....

Continue Reading
A Parish Memoir That Sends Its Proceeds Back Home

Updated Category News Views 142

Some books arrive with a thunderclap; this one shows up carrying a folding chair, a prayer book, and a memory that refuses to leave. You Give Them Something to Eat, the new memoir from Fr. Michael J Rieder, is built from more than a hundred short chapters rather than one grand, polished life story. That choice fits the material. Parish life is rarely a clean parade of...

Continue Reading
Litmus Gets $475 Million as Music Rights Mature Further

Updated Category News Views 115

Music royalties just got another serious pile of institutional money, and Litmus is holding the shovel. The company announced roughly $475 million of new capital commitments from Carlyle and investment funds managed by KKR, a notable vote of confidence in a platform that did not even exist before 2022. This is not some celebrity vanity vehicle buying a famous chorus and...

Continue Reading
Vusion Lands a 2,000-Store dm EdgeSense Rollout in Germany

Updated Category News Views 150

A drugstore shelf rarely gets anyone's pulse racing, but 2,000 of them wired into a live digital system is a serious retail deployment. Vusion has expanded its partnership with dm-drogerie markt to roll out its newest EdgeSense platform across about 2,000 German stores over the next three years. This is not a glossy one-store pilot with a ribbon-cutting and a few tablets...

Continue Reading
MIND Takes Its Copilot Security Bet Across Microsoft 365

Updated Category News Views 81

Copilot’s promise gets a lot less charming the minute confidential files start wandering around unchecked. That is the knot MIND is trying to untie with its expanded, generally available integrations across Microsoft Copilot, Microsoft 365, Purview, Teams, SharePoint, OneDrive, Edge and Exchange. The Seattle data-loss-prevention company announced the collaboration on...

Continue Reading
Vertex Extends Genomics Pact With $220M in Potential

Updated Category News Views 177

Eight years is long enough to separate a useful science partner from a glossy slide deck, and Vertex’s decision to add four more years with Genomics deserves attention. This is not a splashy acquisition, nor is it a clean revenue number investors can plug into next quarter’s model. It is a deeper commitment to the slow, expensive, wonderfully unforgiving business of...

Continue Reading
Perform.AI Tests Whether Stores Can Sell to Agents

Updated Category News Views 98

Shopping bots are about to become one more fussy customer standing in the aisle, except this one reads machine-facing files, rejects broken checkout steps, and does not care how pretty the homepage looks. Perform.AI has launched a free UCP and ACP Readiness Checker aimed at online retailers that need to know whether AI agents can find products, purchase them, and follow...

Continue Reading
Nightguards and TMJ Appliances Require Different Calls

Updated Category News Views 115

Two clear plastic devices can invite a costly wrong turn. Dr. Terrance O’Keefe’s explanation, published Nov. 18, 2026, draws a line that patients too often blur: a nightguard protects teeth from grinding, while a TMJ appliance is meant to address joint and muscle strain tied to temporomandibular disorders. They may look alike sitting in a case. Their jobs are not...

Continue Reading
Fidelis Puts $140,000 Behind Statewide Postpartum Care

Updated Category News Views 83

A missed postpartum appointment can look like a small administrative failure until it is not. Fidelis Care’s $140,000 round of Here for Your Health maternal health grants is aimed squarely at that unglamorous but consequential gap: keeping new mothers connected to care after delivery, particularly in underserved New York communities. Small Dollars, Very Specific...

Continue Reading
Specialty Chemicals Need Demand Before Capacity Bets

Updated Category News Views 96

Empty reactor space does not get filled because everybody suddenly loves reshoring. SOCMA's 2027 Contract Manufacturing Outlook makes that stubborn fact hard to dodge: nearly 70% of surveyed respondents expect North American manufacturing activity to rise over the next three years, yet 79.5% say stronger, more predictable customer demand is critical before future...

Continue Reading

Top 5 Most Recently Viewed Articles

New Terminal One Partners with Plaza Premium to Elevate Travel

Updated Category News Views 234

New Terminal One & Plaza Premium Group Collaboration The New Terminal One at JFK International Airport has joined forces with Plaza Premium Group (PPG), a leading name in airport hospitality, to create two state-of-the-art lounges. Together, they aim to transform the travel experience at this vital international hub, covering close to 14,000 square feet and promising...

Continue Reading
Market Update: S&P 500 Fluctuates After Holiday Trading

Updated Category News Views 337

S&P 500 Experiences Mixed Results in Light Trading The recent trading session saw the S&P 500 close on a flat note after a day of ups and downs, all in the backdrop of lower-than-usual trading volumes, a trend typical of the holiday breakout. As of the market close, the S&P 500 had dipped by 0.1%, while the NASDAQ Composite mirrored this decrease. In contrast, the Dow...

Continue Reading
Brand Engagement Network Expands Horizons with Cataneo Acquisition

Updated Category News Views 104

Brand Engagement Network Expands Strategic Capabilities Jackson, Wyo. – brand Engagement Network, Inc. (NASDAQ: BNAI) has recently made headlines by agreeing to acquire a German media technology powerhouse, Cataneo Gmbh. This acquisition not only highlights BEN's commitment to growth but also demonstrates its ambition to transform how brands use AI to engage with their...

Continue Reading
Metagenomi Showcases Advanced Adenine Base Editors for Gene Therapy

Updated Category News Views 195

Introducing Metagenomi's Innovative Adenine Base Editors Metagenomi has unveiled its cutting-edge Adenine Base Editors (ABEs) at a recent event, highlighting their impressive capabilities in genome editing. These novel tools achieved over 95% targetability in gene modification, demonstrating exceptional performance and efficiency. Key Highlights from the Presentation...

Continue Reading
Streamlining IT Procurement: SysAid Launches on AWS Marketplace

Updated Category News Views 49

SysAid Now Accessible via AWS Marketplace SysAid, a leading Enterprise and IT Service Management solution provider, has made an exciting announcement regarding its availability on AWS Marketplace. This curated digital catalog is designed to simplify the process of discovering, procuring, and deploying software solutions. With AWS Marketplace having over 290,000 active...

Continue Reading